INVESTMENT INTELLIGENCE · 014 · 2026.11.13
Vistra Enters Alpha Watch, but Post-Deal Leverage Still Blocks a Trial Upgrade
ACIS Investment Intelligence | Issue 014 | 13 November 2026
This is a Selection change, not a trading instruction. Weekly owns Evidence; Investment Intelligence owns Decision State. Better operations justify deeper research without bypassing Owner Cash, post-deal capital structure or valuation gates.
Public research | Full access
Vistra moves from sector evidence to Growth / Structural Alpha Watch, but not Trial. Q3 EBITDA, nine-month operating cash, 2027 guidance and long-term PPAs improve visibility into value capture. Acquisition payments, preferred redemption, assumed debt and non-GAAP cash definitions keep the full decision gate open.
The one-minute brief
The only Selection change this week is Vistra entering Alpha Watch. AI data-centre load makes dispatchable power scarcer, and Vistra's operating assets, PPAs and cash-flow guidance sit closer to revenue conversion than greenfield projects. The roughly 5.5GW Cogentrix acquisition also brings integration, interest and deleveraging requirements, while adjusted FCFbG cannot substitute for ordinary free cash flow or Owner Cash. Portfolio / Systemic remains Orange / Defense Review; no new QQQ Beta or SOXX / SMH risk is authorised.
Audio transcript
Vistra enters Alpha Watch, but not Trial. Operating evidence is stronger while capital-structure evidence remains incomplete. Q3 adjusted EBITDA, operating cash, 2027 guidance and long-term PPAs show power demand beginning to convert into company economics. Cogentrix debt, interest, preferred redemption and Owner Cash still require reconciliation. Alpha Watch is a research list, not a buy instruction. Every real investment, trade or position change requires human approval.
01 · SCORE & MEASUREMENT
Evidence maturity, not expected return
States describe Selection and validation gates, not return probability, price target or trading authority.
| Module | Prior | Current | Change / Read |
|---|---|---|---|
| Portfolio / Systemic | ORANGE / DEFENSE REVIEW | ORANGE / DEFENSE REVIEW | Unchanged |
| Vistra | Evidence Positive | ALPHA WATCH | Selection up; no Trial |
| QQQ | ORANGE / NO NEW BETA | ORANGE / NO NEW BETA | Unchanged |
| SOXX / SMH | ORANGE / NO NEW RISK | ORANGE / NO NEW RISK | Unchanged |
| Market Psychology Current | UNKNOWN | UNKNOWN | Expired readings not reused |
02 · WHAT CHANGED
Evidence before narrative
1 | Why Alpha Watch now
Vistra reported Q3 adjusted EBITDA of $2.378bn and nine-month operating cash flow of $4.330bn, while introducing 2027 adjusted EBITDA guidance of $7.7–8.5bn and adjusted FCF-before-growth guidance of $4.3–5.1bn. Company-level evidence now warrants structured-power deep research.
2 | FCFbG is not Owner Cash
Adjusted FCFbG is a company-defined non-GAAP measure. It cannot automatically equal ordinary free cash flow or shareholder cash after interest, maintenance, acquisition consideration and other required capital obligations. The cash-flow bridge remains a separate test.
3 | Post-deal capital structure
The roughly 5.5GW Cogentrix acquisition closed in October. The September balance sheet predates closing, so purchase funding, preferred redemption, assumed debt, interest and integration need a fresh pro-forma bridge. Closing is not deleveraging.
4 | How data-centre PPAs create value
The 405MW Pulaski Solar project entered service under a Microsoft PPA, and Odessa signed a 20-year, 207MW PPA with New Era. Contracts improve demand visibility but still require availability, realised pricing, revenue, CFO and Owner Cash. A PPA is not fully recognised revenue.
5 | Why this is not Trial
Alpha Watch means the evidence merits deeper work. Trial still requires Owner Cash, post-deal leverage, contract conversion, valuation margin of safety and risk-adjusted return to pass together. Public evidence does not yet close every gate.
6 | Portfolio boundary
Portfolio / Systemic remains Orange / Defense Review. No new QQQ Beta or SOXX / SMH risk is authorised, and the state is not an automatic sale, hedge or liquidation. Every real action remains subject to Human Approval.
7 | Counterevidence and next tests
PPA delay, outages, adverse fuel or power prices, integration costs, rating pressure or repurchases that displace deleveraging would weaken the case. Falling net debt, durable Owner Cash, on-time contract ramp and a valuation margin of safety could reopen the Trial gate.
VALUE-CAPTURE MATRIX
One evidence chain, no double counting
| Gate | Confirmed | Still open |
|---|---|---|
| Evidence | EBITDA, CFO, 2027 guide and PPAs | Durability across cycles |
| Cash conversion | Operating cash and company FCFbG guide | Ordinary FCF, Owner Cash and required capital claims |
| Capital structure | Cogentrix closed with liquidity capacity | Pro-forma net debt, interest, integration and deleveraging |
| Selection | Alpha Watch | Trial, Emerging and Confirmed remain closed |
| Action | Human Review | No authority for real trades or positions |
03 · THESIS → EVIDENCE → UPDATE
What the new evidence changes
Prior view
Vistra's operating evidence improved while Selection remained neutral.
New evidence
Cash flow, 2027 guidance, acquired assets and data-centre PPAs provide company-level cross-validation.
Updated view
Alpha Watch; Owner Cash, leverage and valuation continue to block Trial.
04 · NEXT VALIDATION
7D / 30D / 90D
| Window | What to validate |
|---|---|
| 7 days | Complete the Cogentrix pro-forma net-debt, interest and liquidity bridge. |
| 30 days | Validate PPA ramp, availability, ordinary FCF and Owner Cash. |
| 90 days | Review deleveraging, repurchase funding, incremental ROIC and valuation margin of safety. |
FAQ
Questions readers should ask
Does Alpha Watch mean buy?
No. It means sustained deep research, not trading authority.
Why is FCFbG not ordinary free cash flow?
It is an adjusted company measure that must reconcile to the cash-flow statement, growth spending and capital claims.
Does AI data-centre demand guarantee Vistra returns?
No. Contracts, availability, cost, leverage, valuation and per-share cash returns can all change the outcome.
Did Decision State change?
VST Selection moves to Alpha Watch; the portfolio defense state is unchanged and no position action follows automatically.
KEY TERMS
Reader reference
- Alpha Watch
- A deep-research list where operating and valuation evidence has not reached the Trial review gate.
- Owner Cash
- Sustainable cash attributable to owners after maintenance, interest and other required capital claims.
- FCFbG
- Company-defined adjusted free cash flow before growth, requiring reconciliation to ordinary cash flow.
SOURCES & CONTINUITY
Verifiable sources
Vistra | Q3 2026 results | 6 Nov 2026 ↗
SEC | Vistra Q3 2026 Form 10-Q | 6 Nov 2026 ↗
ACIS | Energy & Strategic Resources Weekly 010 | 13 Nov 2026 ↗
Continue reading
Evidence through 20:05 Beijing time on 13 November 2026. The public edition contains directional Decision State, public facts and Human Approval boundaries only. It excludes real holdings, costs, trade plans, internal sizing rules, private valuation sensitivities, client data, prompts and credentials. Not investment advice.
